These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 20668064)

  • 1. Oncogenic Wip1 phosphatase is inhibited by miR-16 in the DNA damage signaling pathway.
    Zhang X; Wan G; Mlotshwa S; Vance V; Berger FG; Chen H; Lu X
    Cancer Res; 2010 Sep; 70(18):7176-86. PubMed ID: 20668064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P65-mediated miR-590 inhibition modulates the chemoresistance of osteosarcoma to doxorubicin through targeting wild-type p53-induced phosphatase 1.
    Long X; Lin XJ
    J Cell Biochem; 2019 Apr; 120(4):5652-5665. PubMed ID: 30387173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The estrogen receptor alpha pathway induces oncogenic Wip1 phosphatase gene expression.
    Han HS; Yu E; Song JY; Park JY; Jang SJ; Choi J
    Mol Cancer Res; 2009 May; 7(5):713-23. PubMed ID: 19435816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of wild-type p53-induced phosphatase 1 (Wip1) plays a critical role in regulating several p53-dependent functions in premature senescent tumor cells.
    Crescenzi E; Raia Z; Pacifico F; Mellone S; Moscato F; Palumbo G; Leonardi A
    J Biol Chem; 2013 Jun; 288(23):16212-16224. PubMed ID: 23612976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A suppressive role of ionizing radiation-responsive miR-29c in the development of liver carcinoma via targeting WIP1.
    Wang B; Li D; Sidler C; Rodriguez-Juarez R; Singh N; Heyns M; Ilnytskyy Y; Bronson RT; Kovalchuk O
    Oncotarget; 2015 Apr; 6(12):9937-50. PubMed ID: 25888625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The type 2C phosphatase Wip1: an oncogenic regulator of tumor suppressor and DNA damage response pathways.
    Lu X; Nguyen TA; Moon SH; Darlington Y; Sommer M; Donehower LA
    Cancer Metastasis Rev; 2008 Jun; 27(2):123-35. PubMed ID: 18265945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylation and degradation of MdmX is inhibited by Wip1 phosphatase in the DNA damage response.
    Zhang X; Lin L; Guo H; Yang J; Jones SN; Jochemsen A; Lu X
    Cancer Res; 2009 Oct; 69(20):7960-8. PubMed ID: 19808970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-15b/16-2 regulates factors that promote p53 phosphorylation and augments the DNA damage response following radiation in the lung.
    Rahman M; Lovat F; Romano G; Calore F; Acunzo M; Bell EH; Nana-Sinkam P
    J Biol Chem; 2014 Sep; 289(38):26406-26416. PubMed ID: 25092292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. WIP1 phosphatase as a potential therapeutic target in neuroblastoma.
    Richter M; Dayaram T; Gilmartin AG; Ganji G; Pemmasani SK; Van Der Key H; Shohet JM; Donehower LA; Kumar R
    PLoS One; 2015; 10(2):e0115635. PubMed ID: 25658463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The oncogenic phosphatase WIP1 negatively regulates nucleotide excision repair.
    Nguyen TA; Slattery SD; Moon SH; Darlington YF; Lu X; Donehower LA
    DNA Repair (Amst); 2010 Jul; 9(7):813-23. PubMed ID: 20451471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of the wip1 gene abrogates the p38 MAPK/p53/Wip1 pathway and silences p16 expression in human breast cancers.
    Yu E; Ahn YS; Jang SJ; Kim MJ; Yoon HS; Gong G; Choi J
    Breast Cancer Res Treat; 2007 Mar; 101(3):269-78. PubMed ID: 16897432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wip1 directly dephosphorylates gamma-H2AX and attenuates the DNA damage response.
    Cha H; Lowe JM; Li H; Lee JS; Belova GI; Bulavin DV; Fornace AJ
    Cancer Res; 2010 May; 70(10):4112-22. PubMed ID: 20460517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of Wip1 phosphatase modulates the cellular threshold of DNA damage signaling in mitosis.
    Macurek L; Benada J; Müllers E; Halim VA; Krejčíková K; Burdová K; Pecháčková S; Hodný Z; Lindqvist A; Medema RH; Bartek J
    Cell Cycle; 2013 Jan; 12(2):251-62. PubMed ID: 23255129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arsenic trioxide augments Chk2/p53-mediated apoptosis by inhibiting oncogenic Wip1 phosphatase.
    Yoda A; Toyoshima K; Watanabe Y; Onishi N; Hazaka Y; Tsukuda Y; Tsukada J; Kondo T; Tanaka Y; Minami Y
    J Biol Chem; 2008 Jul; 283(27):18969-79. PubMed ID: 18482988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA damage-induced regulatory interplay between DAXX, p53, ATM kinase and Wip1 phosphatase.
    Brazina J; Svadlenka J; Macurek L; Andera L; Hodny Z; Bartek J; Hanzlikova H
    Cell Cycle; 2015; 14(3):375-87. PubMed ID: 25659035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel assay for screening WIP1 phosphatase substrates in nuclear extracts.
    Storchova R; Burdova K; Palek M; Medema RH; Macurek L
    FEBS J; 2021 Oct; 288(20):6035-6051. PubMed ID: 33982878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wild-type p53-induced phosphatase 1 down-regulation promotes apoptosis by activating the DNA damage-response pathway in amyotrophic lateral sclerosis.
    Yang YQ; Zheng YH; Zhang CT; Liang WW; Wang SY; Wang XD; Wang Y; Wang TH; Jiang HQ; Feng HL
    Neurobiol Dis; 2020 Feb; 134():104648. PubMed ID: 31676238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of the ATM/ATR-mediated DNA damage response by the oncogenic phosphatase PPM1D.
    Lu X; Nguyen TA; Donehower LA
    Cell Cycle; 2005 Aug; 4(8):1060-4. PubMed ID: 15970689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of Wip1 sensitizes cells to stress- and DNA damage-induced apoptosis.
    Xia Y; Ongusaha P; Lee SW; Liou YC
    J Biol Chem; 2009 Jun; 284(26):17428-37. PubMed ID: 19395378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WIP1, a homeostatic regulator of the DNA damage response, is targeted by HIPK2 for phosphorylation and degradation.
    Choi DW; Na W; Kabir MH; Yi E; Kwon S; Yeom J; Ahn JW; Choi HH; Lee Y; Seo KW; Shin MK; Park SH; Yoo HY; Isono K; Koseki H; Kim ST; Lee C; Kwon YK; Choi CY
    Mol Cell; 2013 Aug; 51(3):374-85. PubMed ID: 23871434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.